Member Info for goupplease

Two out four not bad
o Strengthen Group data packages for treating the effects of Covid-19

o Maximise opportunities for development pipeline especially lead asset, NXP002

o Recruit a CEO with responsibility for delivering the Group's strategy

o Augment and strengthen the Board with additional Non-Executive expertise

To see if the gains hold ,
As you know in history we get a good rns and it falls back .
Hopefully the new team changes history

There must be good news soon

All this time the patents are running down,
It's great to know they are building a good team
But we want action with a decent deal

brazil'
and the other company breast testing
the futures bright but you will have to be ready to wait
also we have a move to main market to look forward to.
ps the bank interest is zero you might as well sit in

you will see fruit here is wait.
when they are ready we will have a deal
theres no hope they had anything in the pipeline .
it was all a dream but it will come or why build the company.
dg was a diaster but we move on

Julian might be fixing a sale for the lot not just a deal !

Was well off target , his dream was well !

My second grandaughter can't walk but I reckon she will take her first step before nfx take theres , bottom drawer

Prop Julian would not have joined to find a brick wall.
But the rns we have waited for still looks far off,but there is light at the end of a very long tunnel

Although there are over 7,000 rare diseases, only around 400 have licensed treatments. Due to the high cost of drug development and low patient population in any given rare disease, investing in research is often not financially viable for the pharmaceutical industry. This leaves millions of patients with no medication to ease their symptoms, and little hope of ever seeing one in their life time. Drug repurposing offers a route to accelerate the development of new treatments while lowering the cost of research.

is Dan Gooding shares
if he was going to sell they would have been gone by now
therefore a deal is there to be taken.

the tils board have a plan, just wait till next year
it will come good
it cant happen overnight

Depends on your personal circumstances,
I see this as as investment
If Brazil results are good for covid this is going to climb
Next 3 months a hold for both shares

I am having a smashing month i if this comes good I can treat the Grandchildren .If my luck holds we will have that rns next week.

the company should issue an rns statement first thing ref state play here

have mugged some ,
sitting was the right policy for us
it will reverse

should not have got caught in the covid sell off ;
if tils are right they will help people whom had it and there are millions of them
I expect people will think and buy back ,its panic not called for.
this company are not a one trick pony any way

why knock nfx, they have not released anything covid/
what nfx propose is to help people whom have had covid and thet are plenty of them,
i suggest this will raise when pople take stock

Is not now,if we are successful in Brazil, I think it's a penalty kick ,the sky the limit ,
By the end of Q1 2021 expect a decent return ,